ClinicalTrials.gg
CompletedNCT07925879Updated Nov 9, 2026

Social Media Perceptions Among Young Adults With Cancer - Aim 1: Interviews

An observational study in Cancer and Cancer Survivors, sponsored by UNC Lineberger Comprehensive Cancer Center. Completed at 1 site in United States. Open to participants aged 22 Years to 39 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by UNC Lineberger Comprehensive Cancer Center · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
33
Ages
22 Years to 39 Years
Sex
All
01

Study summary

This study used one-on-one interviews to understand young adults' with cancer positive and negative in-person social interactions and thoughts about social media messages that encourage in-person interactions with people they barely know. Young adults with cancer (ages 22-39) shared their reactions to mock social media posts and images and described recent in-person interactions with strangers and acquaintances to inform the design of intervention messages, personal stories, and behavioral tips.

Read the detailed description

Participants completed a single, 60-minute semi-structured interview on Zoom following a standardized guide in three parts: 1) sharing a recent positive experience; 2) describing recent in-person interactions with acquaintances and with strangers, including emotional responses, comfort, and experiences discussing their cancer; and 3) reviewing and giving feedback on three image sets (peers experiencing loneliness, peers experiencing connectedness, and spaces where connection could occur) and two mock intervention messages shown as social media posts with a personal story, intervention text, and behavioral tips.

02

Conditions studied

  • Cancer
  • Cancer Survivors

Browse trials for

Keywords

  • Adolescent
  • Message design
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's enrollment of 33 is below the median of 200 across 2,638 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

UNC Lineberger Comprehensive Cancer Center is the lead sponsor of 429 studies on the registry; 97 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 26 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants diagnosed with cancer at ages 15-39 who are currently ages 22-39.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be 22-39 years old
  • Participants must have received a cancer diagnosis at ages 15-39
  • Participants must also receive treatment at adult oncology facilities
  • Participants must also use social media

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
33 participants (actual)
Patient registry
No

Groups and cohorts

  • Participants joined semi-structured interview

    All participants completed a 60-minute semi-structured interview on Zoom, describing recent in-person interactions with strangers and acquaintances and giving feedback on image sets and mock social media intervention messages.

    Behavioral: Semi-structured interview

Interventions

  • BehavioralSemi-structured interview

    60-minute semi-structured interview with review of three image sets (loneliness, connectedness, spaces) and two mock intervention messages (connected peer general story, lonely peer cancer story).

06

What researchers measure

Primary outcomes

  1. Themes in Reactions to Mock Intervention Messages and Images (Semi-Structured Interview Guide; Thematic Analysis)

    Using a standardized semi-structured interview guide, participants reviewed three image sets (peers experiencing loneliness, peers experiencing connectedness, and spaces where connection could occur) and two mock intervention messages formatted as social media posts. Participants described what they liked most and least, what caught their attention, whether the images and posts conveyed their intended meaning, and whether the posts might motivate in-person interactions. Interviews were audio-recorded and professionally transcribed. Two coders independently coded each transcript using a thematic analysis framework with an a priori codebook (refined after initial coding), and disagreements were resolved by consensus.

    Time frame: Baseline, During a single 60-minute interview

Secondary outcomes

  1. Themes in In-Person Interactions With Strangers and Acquaintances (Semi-Structured Interview Guide; Thematic Analysis)

    Using a standardized semi-structured interview guide, participants described recent in-person interactions with acquaintances and with strangers (asked separately), including where the interaction occurred, how it made them feel, situations that made them comfortable, and experiences discussing their cancer. Transcripts were coded for positive and negative social interactions using the same thematic analysis approach. Themes were used to inform intervention message themes, personal stories, and behavioral tips.

    Time frame: Baseline, During a single 60-minute interview

  2. Preferred Social Media Platforms for Intervention Messages (Semi-Structured Interview Guide; Thematic Analysis)

    Using a standardized semi-structured interview guide, participants were asked on which social media platforms they would expect to see posts like the mock intervention messages and whether and how they would share them. Platform preferences were coded and summarized using the same thematic analysis approach.

    Time frame: Baseline, During a single 60-minute interview

07

Study locations

1 site
  • University of North Carolina at Chapel Hill, Department of Radiation Oncology
    Chapel Hill, North Carolina 27599, United States
08

References and documents

Related links

Individual participant data

Plan to share: Yes — De-identified transcripts can be made available upon request secondary to ethics approval.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925879
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Aug 6, 2024
Primary completion
Jan 23, 2025
Completion
Jan 23, 2025
Last update
Nov 9, 2026

Study contacts

Allison J Lazard, PhD
principal investigator · UNC Lineberger Comprehensive Cancer Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion